BR112015023568B8 - Composto à base de metal como composto fotodinâmico - Google Patents

Composto à base de metal como composto fotodinâmico

Info

Publication number
BR112015023568B8
BR112015023568B8 BR112015023568A BR112015023568A BR112015023568B8 BR 112015023568 B8 BR112015023568 B8 BR 112015023568B8 BR 112015023568 A BR112015023568 A BR 112015023568A BR 112015023568 A BR112015023568 A BR 112015023568A BR 112015023568 B8 BR112015023568 B8 BR 112015023568B8
Authority
BR
Brazil
Prior art keywords
complexes
compositions
metal
compound
photodynamic
Prior art date
Application number
BR112015023568A
Other languages
English (en)
Other versions
BR112015023568A2 (pt
BR112015023568B1 (pt
Inventor
Ann Mcfarland Sherri
Original Assignee
Ann Mcfarland Sherri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ann Mcfarland Sherri filed Critical Ann Mcfarland Sherri
Publication of BR112015023568A2 publication Critical patent/BR112015023568A2/pt
Publication of BR112015023568B1 publication Critical patent/BR112015023568B1/pt
Publication of BR112015023568B8 publication Critical patent/BR112015023568B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/002—Osmium compounds
    • C07F15/0026—Osmium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

complexos de coordenação à base de metal como compostos fotodinâmicos e seus usos. a presente invenção se refere a composições que incluem complexos de coordenação à base de metal, que são preferivelmente compostos fotodinâmicos sintonizáveis. as composições e complexos são uteis como agentes terapêuticos e como agentes de diagnóstico in vivo para tratar ou prevenir doenças incluindo aquelas que envolvem células hiperproliferativas em sua etiologia, tais como o câncer. composições e complexos da invenção são ainda capazes de destruir células microbianas, tais como bactérias, fungos e protozoários, e destruir vírus. as composições e complexos também são capazes de modular a função celular de outras maneiras
BR112015023568A 2013-03-15 2014-03-17 Composto à base de metal como composto fotodinâmico BR112015023568B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361801674P 2013-03-15 2013-03-15
US61/801,674 2013-03-15
PCT/US2014/030194 WO2014145428A2 (en) 2013-03-15 2014-03-17 Metal-based coordination complexes as photodynamic compounds and their use

Publications (3)

Publication Number Publication Date
BR112015023568A2 BR112015023568A2 (pt) 2017-07-18
BR112015023568B1 BR112015023568B1 (pt) 2023-04-11
BR112015023568B8 true BR112015023568B8 (pt) 2024-01-02

Family

ID=50687659

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015023568A BR112015023568B8 (pt) 2013-03-15 2014-03-17 Composto à base de metal como composto fotodinâmico

Country Status (7)

Country Link
US (1) US10766915B2 (pt)
EP (1) EP2976347B1 (pt)
CN (1) CN105377862B (pt)
BR (1) BR112015023568B8 (pt)
CA (1) CA2907356C (pt)
RU (1) RU2682674C2 (pt)
WO (1) WO2014145428A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10111936B2 (en) 2015-01-19 2018-10-30 Theralase Technologies, Inc. Metal-glycoprotein complexes and photodynamic therapy of immune privileged sites with same
CN117159705A (zh) 2015-01-19 2023-12-05 锡拉莱斯科技有限公司 金属-糖蛋白复合物及其作为化学治疗化合物的用途
US12109429B2 (en) 2015-07-28 2024-10-08 Know Bio, Llc Phototherapeutic light for treatment of pathogens
EP3328491A4 (en) 2015-07-28 2019-05-01 PhotonMD, Inc. SYSTEMS AND METHOD FOR THE LIGHT THERAPEUTIC MODULATION OF STICK OXIDE
US10335608B2 (en) 2016-04-20 2019-07-02 Theralase Technologies, Inc. Photodynamic compounds and methods for activating them using ionizing radiation and/or other electromagnetic radiation for therapy and/or diagnostics
WO2018204930A1 (en) 2017-05-05 2018-11-08 Intezyne Technologies, Inc. Manufacture of trans-[tetrachlorobis(1h-indazole)ruthenate (iii)] and compositions thereof
US11464798B2 (en) 2017-05-11 2022-10-11 Theralase Technologies Inc. Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
CA3038108C (en) 2018-03-26 2024-06-25 Theralase Technologies, Inc. Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy
US11986666B2 (en) 2020-03-19 2024-05-21 Know Bio, Llc Illumination devices for inducing biological effects
US11147984B2 (en) 2020-03-19 2021-10-19 Know Bio, Llc Illumination devices for inducing biological effects
US12011611B2 (en) 2020-03-19 2024-06-18 Know Bio, Llc Illumination devices for inducing biological effects
CN111939124B (zh) * 2020-07-13 2022-06-28 东南大学 一种金属聚合物、金属聚合物纳米胶束及其制备方法和应用
US11813330B2 (en) * 2021-03-04 2023-11-14 Theralase Technologies, Inc. Sonodynamic therapy using sonodynamically activated coordination complexes of transition metals as sensitizing agents
US12115384B2 (en) 2021-03-15 2024-10-15 Know Bio, Llc Devices and methods for illuminating tissue to induce biological effects
US11654294B2 (en) 2021-03-15 2023-05-23 Know Bio, Llc Intranasal illumination devices

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6239682A (ja) * 1985-08-13 1987-02-20 Fuji Photo Film Co Ltd 赤外線吸収性組成物
CA2005039A1 (en) 1989-12-08 1991-06-08 Randell L. Mills Pharmaceuticals and apparatus providing diagnosis and selective tissue necrosis
AU650878B2 (en) * 1990-04-17 1994-07-07 Ecole Polytechnique Federale De Lausanne Photovoltaic cells
US6362175B1 (en) 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
GB9123814D0 (en) 1991-11-08 1992-01-02 Johnson Matthey Plc Photosensitizers
TW235298B (pt) 1992-02-27 1994-12-01 Ciba Geigy
CA2133284A1 (en) 1994-09-29 1996-03-30 Svetlana Kudrevich Octacarboxy substituted tetra(2,3-pyrazino)porphyrazines and their derivatives
US5648485A (en) 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
RU2089555C1 (ru) 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
AU6274896A (en) 1995-06-06 1996-12-24 Procyte Corporation Stable copper(i) complexes as active therapeutic substances
WO1997000874A1 (en) 1995-06-20 1997-01-09 Pdt Pharmaceuticals, Inc. Efficient functionalization of porphyrin derivatives
CA2237056C (en) 1995-11-24 2006-10-10 Avigdor Scherz Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
CA2221912A1 (en) 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
US6248733B1 (en) 1998-01-09 2001-06-19 3M Innovative Properties Company Method for limiting the growth of microorganisms using metal-containing compounds
ATE255583T1 (de) 1998-07-10 2003-12-15 Meiji Seika Kaisha Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
WO2000033833A1 (en) 1998-12-09 2000-06-15 Yeda Research And Development Co. Ltd. Palladium-substituted bacteriochlorophyll derivatives and use thereof
DK1404319T3 (da) 2001-06-06 2006-07-31 Brookhaven Science Ass Llc Hidtil ukendte metalloporphyriner og anvendelsen deraf som radiosensibilisatorer til strålebehandling
GB0120618D0 (en) 2001-08-24 2001-10-17 Univerity Court Of The Univers Photoreactive compounds and compositions
US7087214B2 (en) 2002-02-01 2006-08-08 Zentaris Gmbh Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
WO2004012667A2 (en) 2002-08-01 2004-02-12 Purdue Research Foundation Photoactivated anti-viral and anti-cancer agent
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
EP1664070B1 (en) 2003-08-13 2008-08-13 University Of South Florida Methods for inhibiting tumor cell proliferation involving platinum complexes
PL197232B1 (pl) * 2004-06-03 2008-03-31 Univ Wroclawski Nowe kompleksy kationowe żelaza(II) i kobaltu(II) z 2,2'-bipirydyną, z 2,2'-bichinoliną i 1,10-fenantroliną oraz ich pochodnymi, sposób wytwarzania tych kompleksów i zastosowanie
GB0418643D0 (en) 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
JP5003871B2 (ja) * 2004-10-01 2012-08-15 宇部興産株式会社 二核金属錯体、金属錯体色素、光電変換素子、及び光化学電池
GB0610062D0 (en) 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
CA2691047A1 (en) 2007-06-18 2008-12-24 Platco Technologies (Proprietary) Limited Platinum (iv) complexes
GB201006762D0 (en) 2010-04-22 2010-06-09 Univ Warwick Osmium (II) arene AZO anti-cancer complexes
GB201008584D0 (en) 2010-05-22 2010-07-07 Univ Warwick Novel iridium anti-cancer compounds
EP2854948B1 (en) 2012-04-15 2019-09-25 McFarland, Sherri Ann Metal-based thiophene photodynamic compounds and their use
PT108082B (pt) 2014-12-06 2020-12-15 Faculdade De Ciências Da Universidade De Lisboa Complexos macromoleculares de metais de transição para o tratamento do cancro e seu processo de preparação
EP3355901A4 (en) 2015-10-01 2019-08-07 Photodynamic Inc. NOVEL EXTRACTS OF POLYGONUM CUSPIDATUM AND THEIR USE AS PHOTODYNAMIC INACTIVATION AGENTS

Also Published As

Publication number Publication date
EP2976347B1 (en) 2022-01-19
BR112015023568A2 (pt) 2017-07-18
BR112015023568B1 (pt) 2023-04-11
EP2976347A2 (en) 2016-01-27
RU2015144121A (ru) 2017-04-21
US10766915B2 (en) 2020-09-08
WO2014145428A3 (en) 2015-01-15
CA2907356C (en) 2022-07-12
CA2907356A1 (en) 2014-09-18
WO2014145428A2 (en) 2014-09-18
CN105377862B (zh) 2019-09-13
RU2682674C2 (ru) 2019-03-20
US20160039854A1 (en) 2016-02-11
CN105377862A (zh) 2016-03-02

Similar Documents

Publication Publication Date Title
BR112015023568B8 (pt) Composto à base de metal como composto fotodinâmico
BR112017015499A2 (pt) ?composição, e, métodos para tratar uma condição associada com células hiperprolifereantes, e para destruir uma célula microbiana?
CY1122984T1 (el) Καρβαμιδικες ενωσεις και μεθοδοι παρασκευης και χρησης τους
NZ752526A (en) Pyrrolobenzodiazepine conjugates
BR112014025702A2 (pt) compostos de tiofeno fotodinâmicos a base de metal e seus usos
CY1119714T1 (el) Ενωσεις αναστολεων
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2020001513A (es) Agentes de union a clec9a y su uso.
BR112014019990A8 (pt) Compostos enediinos, seus conjugados e usos e métodos para esses compostos
BR112017017727A8 (pt) Heterociclos bicíclicos como inibidores de fgfr4
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
MX2016012893A (es) Sustancias terapéuticas combinadas supramoleculares.
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
PH12014502573A1 (en) Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases
EA202092456A3 (ru) Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака
BR112015016002A2 (pt) compostos, composições farmacêuticas, complexos químicos e respectivos usos e método para tratar ou prevenir infecção bacteriana
BR112012011317A2 (pt) antagonistas espiro-oxindóis de mdm2
DOP2010000390A (es) Compuestos de piridina
PE20151023A1 (es) Triazolopirazinas
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
BR112018011228A2 (pt) tratamentos de combinação e seus usos e métodos
BR112012020304A2 (pt) complexo que alveja tecido, uso de um complexo que alveja tecido, método de tratamento de um corpo de animal humano ou não humano, composição farmacêutica, e, kit
MX365392B (es) Composición de combinación de pac-1 y doxorrubicina.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
CY1122968T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει μια ενωση διαμινο-ετεροκυκλικου καρβοξαμιδιου ως δραστικο συστατικο

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25G Requested change of headquarter approved

Owner name: SHERRI ANN MCFARLAND (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/03/2014, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2727 DE 11/04/2023, QUANTO AO ITEM (54) TITULO.